Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1,460 JPY | -0.95% | +1.25% | -16.04% |
2023 | Mithra Pharmaceuticals' License Partner Files for Estelle's Marketing Approval in Japan; Shares Jump | MT |
2023 | Alvotech Partner Secures Marketing Approval for Stelara Biosimilar AVT04 in Japan | MT |
ETFs positioned on Fuji Pharma Co., Ltd.
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.06% | 19 M€ | +8.92% | ||
0.00% | 45 M€ | 0.00% | - | |
0.00% | 17 M€ | +14.54% | - | |
0.00% | 140,441 M€ | +17.07% | ||
0.00% | 63,295 M€ | +17.12% | - | |
0.00% | 20,360 M€ | +15.97% | - |
EPS Revisions
1st Jan change | Capi. | |
---|---|---|
-16.04% | 228M | |
+38.59% | 727B | |
-7.89% | 347B | |
+15.66% | 319B | |
+0.24% | 274B | |
+13.47% | 238B | |
+7.35% | 204B | |
-6.42% | 203B | |
+4.23% | 161B | |
-1.70% | 160B |
- Stock Market
- Equities
- 4554 Stock
- Funds and ETFs Fuji Pharma Co., Ltd.